Exertional Heat Illness: Biomarkers for Prediction and Return to Duty
NCT ID: NCT01434979
Last Updated: 2019-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
148 participants
OBSERVATIONAL
2011-07-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Exertional Heat Illness Risk Factors Between Patients and Controls
NCT05303142
Risk Factors for Exertional Heat Illness
NCT04979455
Physiological Responses to Heat Stress During High-risk Events
NCT06907225
Study of Risk Factors for the Occurrence and Severity of Exertional Heatstroke in the Military Environment
NCT04593316
The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat
NCT01290159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Design: This is a prospective cross-sectional study.
Methodology/Technical Approach: The proposed study will examine multiple biomarkers in a group of 100 individuals who have not had an episode of EHS and a prospective study of 50 persons who have had an EHS event. Control subjects will have biomarker assessments before and after an exercise challenge under thermoneutral (TTT) and thermally challenged conditions (heat tolerance test/HTT); differences in the responses to the two tests will be attributed to the heat. In EHS subjects, blood will be obtained at time of injury and then followed up at 6 weeks according to non-EHS controls. In addition, EHS cases will be prospectively followed at 3, 6, 12, and 18 months after the 6-week post assessment. If they are heat tolerant at 6-weeks as determined by a HTT, subsequent measures will include only blood samples and questionnaires, whereas if they are heat intolerant (HIT) at 6-weeks, subsequent measures will include additional HTTs, along with blood samples and questionnaires. As our previous data indicate, approximately 20% of non-EHS persons are HIT; we will test 100 non-EHS and 50 EHI persons in this study. Thus, data will be evaluated with regard to thermotolerance. Importantly, all control participants will undergo two test sessions (HTT and TTT); to control for an order effect, we will randomize the tests.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controls
Active Duty,DoD Beneficiary, or civilian men and women between the ages of 18 and 45 years, with a waist circumference ≤ 39.4 inches (100 cm) will be asked to participate.
No interventions assigned to this group
Exertional Heat Illness / Stroke
Active duty men and women between the ages of 18 and 45 years will be asked to participate. They must have a clinically documented heat stroke within the last year; they will not be tested any sooner than six weeks following the heat stroke. Heat stroke for the purpose of this study is defined as: a syndrome of hyperthermia, physical collapse or debilitation, and encephalopathy as evidenced by delirium, stupor, or coma, occurring during or immediately following exertion or significant heat exposure.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18 and 45 years
* Waist circumference ≤ 39.4 inches (100 cm)
* Willing to walk/run on a treadmill
* Willing to undergo exposure in a thermal chamber
* Willing to maintain their current activity patterns, and to abstain from alcohol, caffeine, and tobacco for 24 hours prior to all sessions
* For cases who have suffered from a exertional heat illness / exertional heat stroke, must have a clinically documented heat stroke within the past year
Exclusion Criteria
* Pregnant or lactating
* Have overt heart disease
* Have systolic blood pressure over 140 mm Hg, or diastolic pressure over 90 mm Hg
* Have a waist circumference \> 39.4 inches (100 cm)
* Are older than 45 or younger than 18 years of age
* Are anemic
* Are taking psychotropic medication for any mental health disorder
* Are taking other selected medications (glucose lowering, prednisone or beta blockers)
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henry M. Jackson Foundation for the Advancement of Military Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Deuster, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Uniformed Services University of the Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniformed Services University of the Health Sciences
Bethesda, Maryland, United States
Heller Institute of Medical Research
Tel Litwinsky, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G191FY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.